Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Malonic acid-based MMP inhibitors with novel binding properties developed at Roche

April 23, 1999

Monsanto responds to press publication of Celebrex adverse events

April 22, 1999

Phytopharm reports preliminary phase IIa results for P-54 in osteoarthritis

April 22, 1999

FDA advisory committee votes in favor of approval for Vioxx

April 21, 1999

FASEB presentation for PD-159879, an MMP inhibitor with potent antiinflammatory activity

April 21, 1999

New COX-2-selective agents from Abbott

April 21, 1999

Health Canada grants priority review status for rofecoxib

April 20, 1999

New inhibitors of VCAM-1 binding to its receptor patented by Roche

April 20, 1999

Phosphodiesterase inhibition contributes to the antiinflammatory activity of darbufelone

April 19, 1999

Wide series of cytokine production inhibitors reported by JT

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...